NEW YORK–(BUSINESS WIRE)– #creditratingagency–KBRA assigns preliminary ratings to five classes of notes issued by Foundation Finance Trust 2026-2 (“FFIN 2026-2”), an asset-backed securitization collateralized by unsecured consumer loans primarily used for home improvements. FFIN 2026-2 will issue five classes of notes totaling $353.79 million, collateralized by $380.0 million receivables. FFIN 2026-2 has initial credit enhancement levels ranging from 46.90% for the Class A notes to 7.40% for the Class E notes. Cr
Author: sHq_LoGiNz
بولدر، كولورادو–(BUSINESS WIRE)–أعلنت اليوم شركة ParaScript، المتخصصة في مجال معالجة المستندات بالذكاء الاصطناعي، أنَّ شركة Stakk Limited (بورصة أستراليا: SKK) (“Stakk”)، المدرجة للتداول العام في بورصة أستراليا (ASX)، قد أتمت بنجاح استحواذها على شركتي ParaScript, LLC وParaScript Management, Inc. (“ParaScript”) بقيمة 63 مليون دولار أمريكي (88.7 مليون دولار أسترالي)، ما أدى إلى إنشاء منصة موسعة ومربحة للثقة الرقمية قائمة على الذكاء الاصطناعي.استحوذت Stakk على ParaScript بفضل تقنيتها الرائدة في م
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details a
MEXICO CITY–(BUSINESS WIRE)– #insurance–AM Best has affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb+” (Good) of The Hand-in-Hand Mutual Fire Insurance Company Limited (HIHF) (Guyana). The outlook of the FSR is stable while the outlook of the Long-Term ICR is negative. Concurrently, AM Best has affirmed the FSR of B++ (Good) and the Long-Term ICR of “bbb” (Good) of Hand-in-Hand Mutual Life Assurance Company Limited (HIHL) (Guyana). T
México, Ciudad de México–(BUSINESS WIRE)–AM Best ha afirmado la Calificación de Fortaleza Financiera (FSR, por sus siglas en inglés) de B++ (Buena) y la Calificación Crediticia de Emisor de Largo Plazo (ICR, por sus siglas en inglés) de “bbb+” (Buena) de Hand-in-Hand Mutual Fire Insurance Company Limited (HIHF) (Guyana). La perspectiva de la FSR es estable, mientras que la perspectiva de la ICR de Largo Plazo es negativa. Al mismo tiempo, AM Best ha afirmado la FSR de B++ (Buena) y la ICR de L
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–PennyMac Financial Services, Inc. (NYSE: PFSI) will announce results for the quarter ended September 30, 2026, in a news release to be issued after the market close on Thursday, October 29, 2026. The conference call and live audio webcast is being rescheduled to 5:30 pm. Eastern Time from the originally scheduled 5:00 p.m. Eastern Time. The release, webcast, and accompanying materials will be available online at pfsi.pennymac.com. A replay of the webca
DETROIT–(BUSINESS WIRE)– #NextGenHealthcare–NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced Anthony Palladino as Chief Financial Officer. Palladino joins NextGen Healthcare from Thoma Bravo, where he served as an operating partner, working alongside portfolio company leadership teams to strengthen financial operations, improve operating efficiency and accelerate profitable growth across the firm’s software portfolio. Prior to Thoma Bravo, Palladi
CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner Roche announced today late-breaking oral presentation data from the ongoing Phase 3 IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 – 52.0, P<0.0001), relative to placebo at 37 wee
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today late-breaking oral presentation data from the ongoing Phase III IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 – 52.0, P<0.0001), relat
NEW YORK–(BUSINESS WIRE)–Macy’s, Inc. Board of Directors Declares Quarterly Dividend